CTRI/2024/04/065470尚未招募2 期
Randomised Control Trial for addition of aspirin to standard of care in Cervical Cancer patients - Nil
Department of Surgical Oncology0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All Histologically proven cases of primary cervical cancers.
- •Stage I to IV
- •Karnofsky’s performance more than 70
- •ECOG 0 to 2
- •Hb more than 8.0 gm/dL
- •Total count more than 4000 cells/ml
- •Platelet count more than 100000 cells/ml
- •Serum creatinine less than 1.0mg/ml
- •Liver enzymes up to 1.5 times normal
- •Bilirubin less than 1.0mg/ml
排除标准
- •acid peptic disease
- •Pregnancy and ongoing lactation
- •Unwilling to participat
- •NSAID allergy
- •Asthma, rhinitis and nasal polyps
- •Viral fever
- •Use of other blood thinners
- •Bleeding/blood-clotting disorders (such as hemophilia, vitamin K deficiency, low platelet count)
- •pyruvate kinase or G6PD deficiency
- •Patients receiving mifepristone, acetazolamide, corticosteroids, dichlorphenamide, methotrexate, valproic acid
- •Recent anti-viral vaccines
研究者
相似试验
尚未招募
2 期
effect of addition of Aspirin in oral cancer survivalCTRI/2023/05/052737Banaras Hindu University
进行中（未招募）
1 期
Add-on to antipsychotics in the treatment of schizophreniaschizophrenia and schizoaffective disorder.MedDRA version: 17.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 17.0Level: PTClassification code 10039621Term: Schizoaffective disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2014-000757-36-ROClinirx Tangent Research160
已完成
不适用
Tackling heart disease: the Scottish aspirin trialCardiovascular diseaseISRCTN66587262niversity of Edinburgh (UK)3,350
终止
1 期
Safe and effective use of aspirin in intensive care patients.Infection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersSepsisACTRN12611000649910Royal Melbourne Hospital135
已完成
2 期
Statin and Aspirin in SARS-CoV-2 infectioCTRI/2020/07/026791Dr Deepti Siddharthan900